Higher neutrophil to lymphocyte ratio (NLR) is associated with a 33% increased risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention compared to those with lower NLR.
Cohort (n=8,835)
Does elevated neutrophil to lymphocyte ratio combined with type 2 diabetes mellitus predict worse clinical outcomes in CAD patients undergoing percutaneous coronary intervention?
The combination of an elevated neutrophil-to-lymphocyte ratio and type 2 diabetes mellitus identifies a high-risk subgroup of CAD patients undergoing PCI who have significantly worse long-term cardiovascular outcomes.
Effect estimate: HR 0.67 (95% CI 0.52 to 0.87)
p-value: p=0.003
Abstract Background Inflammation plays a crucial role in the pathogenesis and progression of coronary artery disease (CAD). The neutrophil to lymphocyte ratio (NLR) is a novel inflammatory biomarker and its association with clinical outcomes in CAD patients with different glycemic metabolism after percutaneous coronary intervention (PCI) remains undetermined. Therefore, this study aimed to investigate the effect of NLR on the prognosis of patients undergoing PCI with or without type 2 diabetes mellitus (T2DM). Methods We consecutively enrolled 8, 835 patients with CAD hospitalized for PCI at Fuwai hospital. NLR was calculated using the following formula: neutrophil (*10 9 /L) /lymphocyte (*10 9 /L). According to optimal cut-off value, study patients were categorized as higher level of NLR (NLR-H) and lower level of NLR (NLR-L) and were further stratified as NLR-H with T2DM and non-T2DM, and NLR-L with T2DM and non-T2DM. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCEs), defined as all-cause mortality, myocardial infarction (MI), stroke and target vessel revascularization. Results A total of 674 (7. 6%) MACCEs were recorded during a median follow-up of 2. 4 years. The optimal cut-off value of NLR was 2. 85 determined by the survcutpoint function. Compared to those in the NLR-H/T2DM groups, patients in the NLR-L/non-T2DM, NLR-H/non-T2DM and NLR-L/T2DM groups were at significantly lower risk of 2-year MACCEs adjusted hazard ratio (HR): 0. 67, 95% confidence interval (CI): 0. 52 to 0. 87, P = 0. 003; adjusted HR: 0. 62, 95%CI: 0. 45 to 0. 85, P = 0. 003; adjusted HR: 0. 77, 95%CI: 0. 61 to 0. 97, P = 0. 025; respectively. Remarkably, patients in the NLR-L/non-T2DM group also had significantly lower risk of a composite of all-cause mortality and MI than those in the NLR-H/T2DM group (adjusted HR: 0. 57, 95%CI: 0. 35 to 0. 93, P = 0. 024). Multivariable Cox proportional hazards model also indicated the highest risk of MACCEs in diabetic patients with higher level of NLR than others (P for trend = 0. 009). Additionally, subgroup analysis indicated consistent impact of NLR on MACCEs across different subgroups. Conclusions Presence of T2DM with elevated NLR is associated with worse clinical outcomes in CAD patients undergoing PCI. Categorization of patients with elevated NLR and T2DM could provide valuable information for risk stratification of CAD patients.
He et al. (2022) conducted a cohort in Coronary artery disease (n=8,835). Neutrophil to lymphocyte ratio (NLR) vs. NLR-L and glycemic metabolism status was evaluated on Major adverse cardiovascular and cerebrovascular events (MACCEs) (HR 0.67, 95% CI 0.52 to 0.87, p=0.003). Higher neutrophil to lymphocyte ratio (NLR) is associated with a 33% increased risk of major adverse cardiovascular and cerebrovascular events (MACCEs) in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention compared to those with lower NLR.